Details
Stereochemistry | RACEMIC |
Molecular Formula | C17H17NO2 |
Molecular Weight | 267.3224 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC1C2=CC=CC=C2N(C)C(=O)C3=C1C=CC=C3
InChI
InChIKey=BLGFGFHRMMDRPC-UHFFFAOYSA-N
InChI=1S/C17H17NO2/c1-3-20-16-12-8-4-5-9-13(12)17(19)18(2)15-11-7-6-10-14(15)16/h4-11,16H,3H2,1-2H3
Molecular Formula | C17H17NO2 |
Molecular Weight | 267.3224 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/2787643
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2787643
Etazepine (5,6-dihydro-5-methyl-11H-11-ethoxy-dibenzo[b,e]azepin-6-one) demonstrates anticonvulsant activity in rodents. Etazepine seems to exert its anticonvulsant effects by activating the GABAergic system.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2787643
Curator's Comment: Etazepine is CNS active in animals. No human data available.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:45:46 GMT 2023
by
admin
on
Sat Dec 16 17:45:46 GMT 2023
|
Record UNII |
SBC76K7XWC
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C264
Created by
admin on Sat Dec 16 17:45:47 GMT 2023 , Edited by admin on Sat Dec 16 17:45:47 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5533
Created by
admin on Sat Dec 16 17:45:47 GMT 2023 , Edited by admin on Sat Dec 16 17:45:47 GMT 2023
|
PRIMARY | |||
|
DTXSID10868996
Created by
admin on Sat Dec 16 17:45:47 GMT 2023 , Edited by admin on Sat Dec 16 17:45:47 GMT 2023
|
PRIMARY | |||
|
SUB07266MIG
Created by
admin on Sat Dec 16 17:45:47 GMT 2023 , Edited by admin on Sat Dec 16 17:45:47 GMT 2023
|
PRIMARY | |||
|
Etazepine
Created by
admin on Sat Dec 16 17:45:47 GMT 2023 , Edited by admin on Sat Dec 16 17:45:47 GMT 2023
|
PRIMARY | |||
|
88124-27-0
Created by
admin on Sat Dec 16 17:45:47 GMT 2023 , Edited by admin on Sat Dec 16 17:45:47 GMT 2023
|
PRIMARY | |||
|
C060314
Created by
admin on Sat Dec 16 17:45:47 GMT 2023 , Edited by admin on Sat Dec 16 17:45:47 GMT 2023
|
PRIMARY | |||
|
SBC76K7XWC
Created by
admin on Sat Dec 16 17:45:47 GMT 2023 , Edited by admin on Sat Dec 16 17:45:47 GMT 2023
|
PRIMARY | |||
|
100000082391
Created by
admin on Sat Dec 16 17:45:47 GMT 2023 , Edited by admin on Sat Dec 16 17:45:47 GMT 2023
|
PRIMARY | |||
|
C65556
Created by
admin on Sat Dec 16 17:45:47 GMT 2023 , Edited by admin on Sat Dec 16 17:45:47 GMT 2023
|
PRIMARY | |||
|
65662
Created by
admin on Sat Dec 16 17:45:47 GMT 2023 , Edited by admin on Sat Dec 16 17:45:47 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106559
Created by
admin on Sat Dec 16 17:45:47 GMT 2023 , Edited by admin on Sat Dec 16 17:45:47 GMT 2023
|
PRIMARY | |||
|
289-386-1
Created by
admin on Sat Dec 16 17:45:47 GMT 2023 , Edited by admin on Sat Dec 16 17:45:47 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |